Organigram Global Inc.
OGI | NASDAQ
$1.11
-$0.01 (-0.89%)
At close: Sep 22, 2026, 4:00 PM ET
$1.10
-$0.01 (-1.11%)
After-hours:
Sep 22, 2026, 7:50 PM ET
Company Profile
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.
Key Executives
| Name | Position |
|---|---|
| James H. Yamanaka | Chief Executive Officer & Director |
| Adrian Frenzel | Global Chief Operating Officer |
| Greg Guyatt | Chief Financial Officer |
| Helen Martin | Chief Legal Officer & Corporate Secretary |
| Valerie Rother | Chief People Officer |
| Bradley Gunter | Senior Vice President of Sales |
| Max Schwartz | Director of Investor Relations |
| Megan Amber McCrae | Senior Vice President of Corporate Strategy & International Growth |
| Nathalie Batten | Senior Vice President of Operations |
| Paolo De Luca | Chief Strategy Officer |
| Peter L. Amirault | Executive Chairman |
| Timothy Emberg | President of Organigram Canada |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 6-K | Filing |
| Sep 01, 2026 | 6-K | Filing |
| Aug 20, 2026 | 6-K | Filing |
| Aug 11, 2026 | 6-K | Filing |
| Aug 04, 2026 | 6-K | Filing |
| Jul 20, 2026 | 6-K | Filing |
| May 12, 2026 | 6-K | Filing |
| May 06, 2026 | 6-K | Filing |
| Apr 17, 2026 | SC 13D/A | [Amend] Filing |
| Apr 16, 2026 | 6-K | Filing |
Organigram Global Inc.
| Country | Canada |
| IPO Date | May 20, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,139 |
| CEO | James Yamanaka |
Contact Details
145 King Street West Toronto,
ON M5H 1J8 Canada
Stock Details
| Ticker Symbol | OGI |
| Exchange | NASDAQ |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| CIK Code | 0001620737 |
| CUSIP Number | 68617J100 |
| ISIN Number | CA68617J1003 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove OGI